Monogenic diabetes affects up to 5% of pediatric patients, and testing for it prevents misdiagnosis, suboptimal treatment, and delays in diagnosing other family members.3,4 Monogenic diabetes has also been identified in adults in their 40s and even 50s.
We offer testing for maturity-onset diabetes of the young (MODY), the most common type of monogenic diabetes, as well as neonatal diabetes mellitus (NDM), a rarer form.3 Many pediatric patients with MODY are mistakenly diagnosed with type 1 diabetes, whereas older patients with MODY (in their 20s and 30s) are often thought to have type 2 diabetes.4 Our MODY DNA sequencing testing helps you take the doubt out of your diagnosis, so you can identify MODY and get patients on the appropriate treatment path.
In addition to being the only major commercial lab that offers genetic testing for MODY, we offer:
- Comprehensive insulin autoantibody testing for type 1 diabetes and LADA
- Insulin production status, using tests for insulin, C-peptide, and proinsulin, including LC/MS/MS assays, which are more precise and reliable than immunoassays5
Learn more about our differential diagnostic tools:
Find out about monitoring patients with diabetes